Thomas Aoki, et al v. Bionica, Inc., et al
| DEEPAL CEMO MEDICAL SOLUTIONS, LLC, BIONICA, INT'L, INC., a California Limited Liability Company, DIABETIC INNOVATIONS, LLC, a Texas Limited Liability Company, MARC R. ROSE, M. D, CHENG SHAO, MICHAEL R. MCCARTHY, DEEPAL WANNAKUWATTE, LIMI MANAGEMENT, INC., TRINA HEALTH OF NEWPORT BEACH, LLC, a California Limited Liability Company, JOHN D. MULLEN, KEVIN J. BUCKMAN, M. D., DIABETIC LIFE PULSE, INC., DAVID S. BRADLEY, SHUYUAN TANG, "Sherry", MEDEDCO, LLC, an Arizona Limited Liability Company, LIFE PULSE HEALTH, LLC, HEALTH INNOVATIONS, LP, GLENN A. WILSON, TRINA HEALTH, LLC, a California Limited Liability Company, RICHARD L. GIRARD, GREGORY FORD GILBERT, FAISING S. CHUI, MELANIE J. KUNZ, ACSRC, LLC, TIMOTHY TIGHT, SAMMY F. CEMO, GARY J. MUGG and DIABETIC LIFE PULSE OF LOUISIANA, LLC |
| AOKI DIABETES RESEARCH INSTITUTE, a California Non-Profit Corporation and THOMAS T. AOKI, M. D. |
| UNIVERSITY OF CALIFORNIA DAVIS, SCHOOL OF MEDICINE and UNIVERSITY OF CALIFORNIA DAVIS |
| BIONICA, INC., a Nevada Corporation |
| 21-15582 |
| April 1, 2021 |
| U.S. Court of Appeals, Ninth Circuit |
| Other |
Docket Report
RSS Track this Docket
This docket was last retrieved on April 29, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 7 Filed order MEDIATION (RSK): These cases are RELEASED from the Mediation Program. Counsel are requested to contact the Circuit Mediator should circumstances develop that warrant settlement discussions. [12096652] [21-15518, 21-15582] (AF) [Entered: 04/29/2021 10:25 AM] |
| Filing 6 The Mediation Questionnaire for this case was filed on 04/28/2021. To submit pertinent confidential information directly to the Circuit Mediators, please use the following # link . Confidential submissions may include any information relevant to mediation of the case and settlement potential, including, but not limited to, settlement history, ongoing or potential settlement discussions, non-litigated party related issues, other pending actions, and timing considerations that may impact mediation efforts.[12090541]. [21-15582] (AD) [Entered: 04/28/2021 06:44 PM] |
| Filing 5 Filed (ECF) Appellant Bionica, Inc. Mediation Questionnaire. Date of service: 04/28/2021. [12090109] [21-15582] (Barrett, David) [Entered: 04/28/2021 02:10 PM] |
| Filing 4 Filed order MEDIATION (VS): The Mediation Program of the Ninth Circuit Court of Appeals facilitates settlement while appeals are pending. See Fed. R. App. P. 33 and Ninth Cir. R. 33-1. The court has scheduled a dial-in telephone assessment conference with counsel and Circuit Mediator Robert Kaiser at the date and time indicated above to explore settlement potential. Each attorney on the attached list of participants will receive an email with dial-in information. If there are any changes or additions to the list, please notify the Mediation Office at mediation@ca9.uscourts.gov. Also, if counsel has an unavoidable scheduling conflict, please notify Circuit Mediator Robert Kaiser immediately by email (robert_kaiser@ca9.uscourts.gov) and copy all counsel on any such communications. All emails should include the Ninth Circuit case name and number in the subject line. All discussions that take place in the context of the assessment conference are confidential. See Circuit Rule 33-1. For more detailed information about the assessment conference, confidentiality, and the Mediation Program and its procedures generally, please see the attachment to this order and the Mediation Program web site: www.ca9.uscourts.gov/mediation. The briefing schedules previously set by the court remain in effect. (Date: April 29, 2021 Time: 9:00 a.m. Pacific Time) (SEE ORDER FOR FULL TEXT) [12077687] [21-15518, 21-15582] (AF) [Entered: 04/16/2021 02:47 PM] |
| Filing 3 Filed order MEDIATION (LW): The Court of Appeals records do not indicate that appellant has filed a Mediation Questionnaire in accordance with Circuit Rule 3-4. Within seven (7) days of the filing of this order, appellant shall: (a) file a Mediation Questionnaire (available on the courts website: www.ca9.uscourts.gov), or (b) dismiss the appeal voluntarily pursuant to Fed.R.App.P. 42(b). Information about the mediation program may be found on the courts website: www.ca9.uscourt.gov/mediation. [12076225] (AF) [Entered: 04/15/2021 03:45 PM] |
| Filing 2 Fee status changed ( [Case Number 21-15582: Paid] ). [12075740] (TSP) [Entered: 04/15/2021 12:48 PM] |
| Filing 1 DOCKETED CAUSE AND ENTERED APPEARANCES OF COUNSEL. SEND MQ: Yes. The schedule is set as follows: Appellant Bionica, Inc. Mediation Questionnaire due on 04/08/2021. Transcript ordered by 04/30/2021. Transcript due 06/01/2021. Appellant Bionica, Inc. opening brief due 07/09/2021. Appellees Thomas T. Aoki and Aoki Diabetes Research Institute answering brief due 08/09/2021. Appellant's optional reply brief is due 21 days after service of the answering brief. [12060576] (JBS) [Entered: 04/01/2021 10:44 AM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
